To prepare for advanced stage clinical trials investigating vaccine efficacy in the field, suitable epidemiological data is needed to support trial design and strengthen site and investigator capacity to conduct these trials.
CEPI is therefore providing grants for epidemiological studies that will contribute these data. These two-year prospective studies will be performed in five countries in West Africa (Nigeria, Benin, Sierra Leone, Liberia, and Guinea), with the primary objective of assessing incidence of symptomatic Lassa fever cases as well as incidence of Lassa virus infection as well as secondary objectives informing additional aspects of future phase 2b/3 clinical trials.
In CEPI’s role as the facilitator and funder for these epidemiology studies, CEPI now seeks to identify a qualified coordinating institution to support this large-scale, five-country programme from the planning and implementation phases through to close-out. This institution will develop and implement a coordination framework ensuring robust oversight, performance and capacity monitoring, and quality management of all activities across the five study countries for the duration of the Lassa epidemiology programme.
The identified institution will also facilitate the harmonized planning and analysis of study data, including the development of a programme statistical analysis plan and conduct of all programme-level analyses. Finally, the institution will provide support as needed in training curriculum development and provision, including harmonization of content and delivery across study consortia.
Please download the full tender below.
If you are considering submitting a proposal, please send an email to [email protected] by 6 January 2020.
Support CEPI
Calls for Proposals
Our portfolio
Platform Technology
Priority diseases
Vaccine science
Why we exist
Who we are
Governance